![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SDHD |
Gene summary for SDHD |
![]() |
Gene information | Species | Human | Gene symbol | SDHD | Gene ID | 6392 |
Gene name | succinate dehydrogenase complex subunit D | |
Gene Alias | CBT1 | |
Cytomap | 11q23.1 | |
Gene Type | protein-coding | GO ID | GO:0006091 | UniProtAcc | A0A0S2Z4H7 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
6392 | SDHD | HTA11_3410_2000001011 | Human | Colorectum | AD | 5.90e-11 | 2.41e-01 | 0.0155 |
6392 | SDHD | HTA11_2487_2000001011 | Human | Colorectum | SER | 2.14e-15 | 4.33e-01 | -0.1808 |
6392 | SDHD | HTA11_2951_2000001011 | Human | Colorectum | AD | 3.34e-04 | 2.80e-01 | 0.0216 |
6392 | SDHD | HTA11_1938_2000001011 | Human | Colorectum | AD | 8.04e-15 | 5.17e-01 | -0.0811 |
6392 | SDHD | HTA11_78_2000001011 | Human | Colorectum | AD | 6.88e-27 | 6.94e-01 | -0.1088 |
6392 | SDHD | HTA11_347_2000001011 | Human | Colorectum | AD | 1.41e-41 | 7.73e-01 | -0.1954 |
6392 | SDHD | HTA11_411_2000001011 | Human | Colorectum | SER | 1.35e-12 | 8.01e-01 | -0.2602 |
6392 | SDHD | HTA11_3361_2000001011 | Human | Colorectum | AD | 3.26e-09 | 3.70e-01 | -0.1207 |
6392 | SDHD | HTA11_83_2000001011 | Human | Colorectum | SER | 1.12e-08 | 3.22e-01 | -0.1526 |
6392 | SDHD | HTA11_696_2000001011 | Human | Colorectum | AD | 2.10e-17 | 3.37e-01 | -0.1464 |
6392 | SDHD | HTA11_866_2000001011 | Human | Colorectum | AD | 7.82e-13 | 2.67e-01 | -0.1001 |
6392 | SDHD | HTA11_1391_2000001011 | Human | Colorectum | AD | 3.44e-15 | 3.55e-01 | -0.059 |
6392 | SDHD | HTA11_2992_2000001011 | Human | Colorectum | SER | 7.86e-21 | 7.82e-01 | -0.1706 |
6392 | SDHD | HTA11_5212_2000001011 | Human | Colorectum | AD | 2.13e-20 | 7.47e-01 | -0.2061 |
6392 | SDHD | HTA11_5216_2000001011 | Human | Colorectum | SER | 2.49e-08 | 4.90e-01 | -0.1462 |
6392 | SDHD | HTA11_546_2000001011 | Human | Colorectum | AD | 4.83e-05 | 2.45e-01 | -0.0842 |
6392 | SDHD | HTA11_7862_2000001011 | Human | Colorectum | AD | 5.05e-17 | 6.40e-01 | -0.0179 |
6392 | SDHD | HTA11_866_3004761011 | Human | Colorectum | AD | 5.18e-29 | 5.68e-01 | 0.096 |
6392 | SDHD | HTA11_4255_2000001011 | Human | Colorectum | SER | 1.84e-10 | 4.41e-01 | 0.0446 |
6392 | SDHD | HTA11_8622_2000001021 | Human | Colorectum | SER | 3.15e-09 | 4.03e-01 | 0.0528 |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0046034 | Colorectum | AD | ATP metabolic process | 142/3918 | 277/18723 | 2.64e-29 | 8.26e-26 | 142 |
GO:0006091 | Colorectum | AD | generation of precursor metabolites and energy | 209/3918 | 490/18723 | 3.17e-28 | 6.61e-25 | 209 |
GO:0009060 | Colorectum | AD | aerobic respiration | 108/3918 | 189/18723 | 9.14e-28 | 1.43e-24 | 108 |
GO:0045333 | Colorectum | AD | cellular respiration | 119/3918 | 230/18723 | 3.21e-25 | 4.02e-22 | 119 |
GO:0006119 | Colorectum | AD | oxidative phosphorylation | 83/3918 | 141/18723 | 7.95e-23 | 8.30e-20 | 83 |
GO:0015980 | Colorectum | AD | energy derivation by oxidation of organic compounds | 143/3918 | 318/18723 | 2.78e-22 | 2.49e-19 | 143 |
GO:0022900 | Colorectum | AD | electron transport chain | 89/3918 | 175/18723 | 1.42e-18 | 8.91e-16 | 89 |
GO:0019646 | Colorectum | AD | aerobic electron transport chain | 53/3918 | 87/18723 | 5.58e-16 | 2.16e-13 | 53 |
GO:0042773 | Colorectum | AD | ATP synthesis coupled electron transport | 56/3918 | 95/18723 | 6.76e-16 | 2.22e-13 | 56 |
GO:0042775 | Colorectum | AD | mitochondrial ATP synthesis coupled electron transport | 56/3918 | 95/18723 | 6.76e-16 | 2.22e-13 | 56 |
GO:0022904 | Colorectum | AD | respiratory electron transport chain | 63/3918 | 114/18723 | 8.23e-16 | 2.45e-13 | 63 |
GO:0006099 | Colorectum | AD | tricarboxylic acid cycle | 19/3918 | 30/18723 | 5.82e-07 | 2.09e-05 | 19 |
GO:00090601 | Colorectum | SER | aerobic respiration | 96/2897 | 189/18723 | 5.53e-30 | 1.70e-26 | 96 |
GO:00460341 | Colorectum | SER | ATP metabolic process | 117/2897 | 277/18723 | 5.54e-27 | 1.13e-23 | 117 |
GO:00453331 | Colorectum | SER | cellular respiration | 103/2897 | 230/18723 | 2.35e-26 | 3.61e-23 | 103 |
GO:00060911 | Colorectum | SER | generation of precursor metabolites and energy | 168/2897 | 490/18723 | 1.39e-25 | 1.70e-22 | 168 |
GO:00061191 | Colorectum | SER | oxidative phosphorylation | 75/2897 | 141/18723 | 2.35e-25 | 2.40e-22 | 75 |
GO:00159801 | Colorectum | SER | energy derivation by oxidation of organic compounds | 119/2897 | 318/18723 | 5.28e-22 | 4.62e-19 | 119 |
GO:00229001 | Colorectum | SER | electron transport chain | 77/2897 | 175/18723 | 1.77e-19 | 1.36e-16 | 77 |
GO:00427731 | Colorectum | SER | ATP synthesis coupled electron transport | 51/2897 | 95/18723 | 6.48e-18 | 3.98e-15 | 51 |
Page: 1 2 3 4 5 6 7 8 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0501037 | Oral cavity | LP | Alzheimer disease | 197/2418 | 384/8465 | 6.66e-22 | 3.69e-20 | 2.38e-20 | 197 |
hsa0502237 | Oral cavity | LP | Pathways of neurodegeneration - multiple diseases | 232/2418 | 476/8465 | 7.77e-22 | 3.69e-20 | 2.38e-20 | 232 |
hsa0493237 | Oral cavity | LP | Non-alcoholic fatty liver disease | 101/2418 | 155/8465 | 1.53e-21 | 6.37e-20 | 4.10e-20 | 101 |
hsa0502037 | Oral cavity | LP | Prion disease | 149/2418 | 273/8465 | 4.88e-20 | 1.81e-18 | 1.16e-18 | 149 |
hsa0520838 | Oral cavity | LP | Chemical carcinogenesis - reactive oxygen species | 119/2418 | 223/8465 | 3.00e-15 | 8.32e-14 | 5.37e-14 | 119 |
hsa0019037 | Oral cavity | LP | Oxidative phosphorylation | 81/2418 | 134/8465 | 9.58e-15 | 2.45e-13 | 1.58e-13 | 81 |
hsa0541537 | Oral cavity | LP | Diabetic cardiomyopathy | 106/2418 | 203/8465 | 6.51e-13 | 1.36e-11 | 8.74e-12 | 106 |
hsa0120032 | Oral cavity | LP | Carbon metabolism | 62/2418 | 115/8465 | 8.38e-09 | 1.39e-07 | 8.99e-08 | 62 |
hsa0471438 | Oral cavity | LP | Thermogenesis | 105/2418 | 232/8465 | 3.14e-08 | 4.98e-07 | 3.21e-07 | 105 |
hsa0002032 | Oral cavity | LP | Citrate cycle (TCA cycle) | 22/2418 | 30/8465 | 4.66e-07 | 5.97e-06 | 3.85e-06 | 22 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SDHD | SNV | Missense_Mutation | c.350N>T | p.Gly117Val | p.G117V | O14521 | protein_coding | deleterious(0.04) | possibly_damaging(0.446) | TCGA-AA-A010-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | folinic | CR | |
SDHD | SNV | Missense_Mutation | c.10N>T | p.Leu4Phe | p.L4F | O14521 | protein_coding | tolerated(0.06) | possibly_damaging(0.499) | TCGA-AZ-6599-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
SDHD | SNV | Missense_Mutation | c.200N>T | p.Thr67Ile | p.T67I | O14521 | protein_coding | deleterious(0.01) | possibly_damaging(0.888) | TCGA-CK-6746-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
SDHD | SNV | Missense_Mutation | c.65G>A | p.Arg22Gln | p.R22Q | O14521 | protein_coding | tolerated(0.63) | benign(0) | TCGA-F5-6814-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
SDHD | SNV | Missense_Mutation | c.134N>T | p.Gly45Val | p.G45V | O14521 | protein_coding | tolerated(0.15) | benign(0.074) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | |
SDHD | SNV | Missense_Mutation | rs758784300 | c.356N>T | p.Ala119Val | p.A119V | O14521 | protein_coding | tolerated(0.17) | benign(0.005) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
SDHD | SNV | Missense_Mutation | c.65N>A | p.Arg22Gln | p.R22Q | O14521 | protein_coding | tolerated(0.63) | benign(0) | TCGA-AP-A056-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
SDHD | SNV | Missense_Mutation | c.466N>A | p.Leu156Met | p.L156M | O14521 | protein_coding | deleterious(0) | probably_damaging(0.977) | TCGA-AP-A059-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
SDHD | SNV | Missense_Mutation | rs202198133 | c.205N>A | p.Glu69Lys | p.E69K | O14521 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-BS-A0UV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
SDHD | SNV | Missense_Mutation | c.65N>A | p.Arg22Gln | p.R22Q | O14521 | protein_coding | tolerated(0.63) | benign(0) | TCGA-EO-A3AV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | CR |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |